Asenapine Transdermal Patch Generics - Manufacturers & Suppliers
Secuado®(US)
| Product/Composition:- | Asenapine Transdermal Patch |
|---|---|
| Strength:- | 3.8 mg/24 hr, 5.7 mg/24 hr, 7.6 mg/24 hr |
| Form:- | Transdermal Patch |
| Reference Brands:- | Secuado®(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Asenapine is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, helping to manage symptoms like hallucinations, delusions, and mood instability. The transdermal patch delivers medication steadily through the skin, ensuring consistent blood levels. It is used for the treatment of schizophrenia in adults, especially beneficial for patients who have difficulty with oral medications or require non-invasive, once-daily dosing.
The Asenapine transdermal patch is FDA-approved in the United States (brand name: Secuado) for the treatment of schizophrenia in adults. It is the first and only transdermal antipsychotic approved in the U.S. As of now, it is not approved in the European Union, and marketing would require a new MAA (Marketing Authorization Application) via national or centralized procedures. Regulatory requirements in the U.S. include GMP-compliant patch manufacturing, transdermal pharmacokinetics, adhesion and skin safety data, and documentation addressing risks like extrapyramidal symptoms and QT prolongation. U.S. labeling includes warnings for elderly dementia-related psychosis. To explore dossier-ready Asenapine transdermal patches and alternatives, visit Pharmatradz.com — your global B2B pharma sourcing hub.